President Donald Trump claims the World Health Organization failed to investigate early reports of the coronavirus, while public health experts argue that stripping the agency of its funding endangers us all.
As the first clinical data become available on treating coronavirus patients with the cells, scientists are equivocal about the rationale for the intervention.
Mauro Ferrari says the organization’s response to the COVID-19 pandemic is inadequate, but ERC members claim his proposals didn’t align with the mission of the council.
School shutdowns might have a relatively small effect on preventing the transmission of SARS-CoV-2, a new meta-analysis suggests, though the preliminary data point to the need for more studies.
There is little evidence that antihypertensive drugs worsen COVID-19, and scientists are instead exploring the idea that such medications—or their downstream effects—may actually alleviate symptoms.
The small number of genetic differences between the original strain of the novel coronavirus from Wuhan and those currently circulating in the US population indicates that a vaccine may likely offer lasting immunity.
President Donald Trump has touted the drug as a treatment but scientists still don’t know for sure that it is effective in patients. A number of clinical trials aim to find out.
With mounting feelings of isolation, research projects derailed, and financial futures cast into doubt, grad students are anxious in the midst of the COVID-19 outbreak.
Rhesus macaques can be infected with SARS-CoV-2, leading primate center scientists to try to prevent outbreaks in their colonies, especially as experiments on coronavirus start.
Amy Schleunes and Catherine Offord | Mar 19, 2020 | 1 min read
International data from the European Centre for Disease Prevention and Control indicates a similar pattern in reported coronavirus cases during the first 10 days after the case count passes 500.